Welcome back readers. This we had to execute periods 3
through 7 in the simulation. This was the focus of our week and I assure you,
it was not easy. In the first few
periods we tried to adjust to reverse course for any negative trend while
staying in our strategy. This did not work very well. We also had planned to
release a new allergy product that the simulation did not allow us to release.
We chose instead to release a new product at all until later when we could
introduce an allergy product. A part of our strategy was to consistently
increase our price based on inflation and competitor pricing. A couple times we
forgot to do this however so we left potential profit on the table. As we
released our new product and we saw the overall market begin to shrink we saw
our cash flows significantly decrease. To offset this, we had to reallocate
resources while staying true to our strategy. Our allergy product did very well
but as we reallocated our budget from Allround to our allergy product we saw a
decrease in sales for Allround which cut into our revenue.
We feel confident about where we are currently but it was a
struggle. We can see the potential for where we can go and the future looks
positive for our company. As we have stopped looking so deeply into the
statistics and trying to focus more on our strategy implementation we have seen
promise. Hopefully all the potential we see will soon be realized.
No comments:
Post a Comment